In conclusion, OTX008, by preventing the pro-fibrotic processes activated by Gal-1 in a cell line strictly involved in the pathogenic mechanisms of diabetes- or hyperglycemia-related eye diseases, candidates itself as good therapeutic tool to treat them. Here, LGALS1 is linked to eye disorder.